Thymus & immune
One of 5 mechanistic pathways to 🧬 Organ-specific bioregulation · 5 options
The original and best-supported target — the thymus involutes with age on a schedule you can almost set a watch by, which makes it the most defensible place to argue that restoring a tissue signal could matter.
The lymphocyte count is the one readable output of thymic function available on a routine panel — worth a baseline before and after a cycle, since it is the only way you'd know whether anything happened.
Complete Blood Count (CBC) with Differentialhs-CRP (High-Sensitivity C-Reactive Protein)Vitamin D (25-Hydroxy)Zinc, RBC🛡️ Frequent Illness & Immune Resilience covers these in one panel →
What engages this pathway
Ordered by how directly each one acts on the mechanism above — never by how much trial evidence exists. Each links to its full breakdown with dosing, half-life and vendor.
💉 Thymalin
The thymus extract with the programme's most cited result — a long-term follow-up reporting reduced mortality in treated elderly cohorts. Extraordinary claim, single source, never independently repeated.
💉 Thymogen
The synthetic dipeptide (Glu-Trp) derived from thymalin's active fragment — the reductionist version of the same signal.
💉 Vladonix
Oral thymus bioregulator for the same target.
💉 Crystagen
Immune-system peptide bioregulator from the same series.
💉 Thymosin Alpha 1
Not a Khavinson peptide — included because it is the thymic peptide that DID go through Western clinical development, and it is the honest benchmark for what this class could look like with real trials behind it.
The other 4 routes to organ-specific bioregulation
Pick the pathway that matches where you are actually stuck. An appetite drug does nothing for someone who already undereats.
Want the protocols behind these?
Dosing schedules, stacking, cycle timing and Coach Cam's notes live inside the Academy — plus the full interactive Vault.
Join the Academy — $10/mo →← Open this pathway in the interactive Vault
Frequently asked questions
The original and best-supported target — the thymus involutes with age on a schedule you can almost set a watch by, which makes it the most defensible place to argue that restoring a tissue signal could matter.
5 options are mapped to this pathway in the Vault, including Thymalin, Thymogen, Vladonix, Crystagen. They are grouped by the mechanism they act through rather than ranked by how much trial evidence exists — 1 carry clinical validation and 4 are mechanistic predictions.
The lymphocyte count is the one readable output of thymic function available on a routine panel — worth a baseline before and after a cycle, since it is the only way you'd know whether anything happened. The markers worth checking are Complete Blood Count (CBC) with Differential, hs-CRP (High-Sensitivity C-Reactive Protein), Vitamin D (25-Hydroxy), Zinc, RBC.
Unproven is not the same as ineffective. Of the 5 options on this pathway, 1 have clinical validation and 4 are graded theoretical — meaning the mechanism is sound but the specific human trial has not been run, which is true of a great deal of what works in this space. Nothing on this page is ordered by evidence tier, because sorting by trial count would bury the compounds you came looking for.